Year

2020

Status

Active

Team

 

Field

Autoimmune Diseases

Location

Oss (Netherlands)

Fund

BGV IV

Citryll

Citryll  focuses on the development of a therapeutic antibody that inhibits neutrophil extracellular traps and their formation that are associated with a number of inflammatory diseases.